Modulation of dose intensity in aerodigestive tract cancers: Strategies to reduce toxicity

ONCOLOGY

Volumn 15, Issue 12, 2001, Pages 1603-1613

  Rich, Tyvin A ^a   Kirichenko, Alexander V ^a   Sewell, Rowley ^a   Straume, Martin ^b  

^a Department of Radiation Oncology ^*

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; DIGESTIVE SYSTEM TUMOR; HUMAN; METHODOLOGY; QUALITY OF LIFE; RADIATION DOSE; RESPIRATORY TRACT TUMOR; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RESPIRATORY TRACT NEOPLASMS; TREATMENT OUTCOME;

EID: 0035748521     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Fu KK, Pajak TF, Trotti A, et al: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48(1):7-16, 2000.
2. Horiot JC, Bontemps P, Van den BW, et al: Accelerated fractionation (AF) compared to conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial. Radiother Oncol 44(2):111-121, 1997.
3. Nishimura Y, Ono K, Tsutsui K, et al: Esophageal cancer treated with radiotherapy: Impact of total treatment time and fractionation. Int J Radiat Oncol Biol Phys 30(5):1099-1105, 1994.
4. Withers HR, Taylor JM, Maciejewski B: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27(2):131-146, 1988.
5. Taylor JM, Withers HR, Mendenhall WM: Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol 17(2):95-102, 1990.
6. Norton L: Kinetic concepts in the systemic drug therapy of breast cancer. Semin Oncol 26(1 suppl 2):11-20, 1999.
7. Bentzen SM, Ruifrok AC, Thames HD: Re-pair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: Clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy. Radiother Oncol 38(2):89-101, 1996.
8. Rich TA: Chemoradiation or accelerated fractionation: Basic considerations. J Infus Chemother 1:2-8, 1992.
9. Rich T: Changing role of radiotherapy in the management of cancer of the esophagus. South Med J 92(11): 1054-1063, 1999.
10. Rich TA: Infusional Chemoradiation for rectal and anal cancers. Oncology 13(10 suppl 5):131-134, 1999.
11. Rich TA: Chemoradiation for pancreatic and biliary cancer: Current status of RTOG studies. Ann Oncol 10 (suppl 4):231-233, 1999.
12. Bedford JL, Viviers L, Guzel Z, et al: A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the esophagus. Radiother Oncol 57(2): 183-193, 2000.
13. Ling CC, Humm J, Larson S, et al: Towards multidimensional radiotherapy (MDCRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47(3):551-560, 2000.
14. Wu Q, Manning M, Schmidt-Ullrich R, et al: The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: A treatment design study. Int J Radiat Oncol Biol Phys 46(1):195-205, 2000.
15. Perez CA, Michalski JM, Purdy JA, et al: Three-dimensional conformal therapy or standard irradiation in localized carcinoma of prostate: Preliminary results of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 47(3):629-637, 2000.
16. Robertson JM, McGinn CJ, Walker S, et al: A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases. Int J Radiat Oncol Biol Phys 39(5):1087-1092, 1997.
17. Cheng SH, Lin YM, Chuang VP, et al: A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma. J Gastroenterol Hepatol 14(10):1025-1033, 1999.
18. Ceha HM, van Tienhoven G, Gouma DJ, et al: Feasibility and efficacy of high-dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer 89(11):2222-2229, 2000.
19. Ramsey CR, Scaperoth D, Arwood D, et al: Clinical efficacy of respiratory gated conformal radiation therapy. Med Dosim 24(2): 115-119, 1999.
20. Peters LJ, Withers HR: Applying radiobiological principles to combined modality treatment of head and neck cancer - The time factor. lut J Radiat Oncol Biol Phys 39(4):831-836,1997.
21. Horwitz EM, Hanlon AL, Pinover WH, et al: The cost effectiveness of 3-D conformal radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 45(5):1219-1225, 1999 (see comments).